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Abstract 
Background/Aims: The diterpene alcohol Sclareol has been proposed for the treatment of 
malignancy. In analogy to apoptosis of nucleated cells, erythrocytes may enter eryptosis, 
a suicidal cell death characterized by cell shrinkage and cell membrane scrambling with 
phosphatidylserine translocation to the erythrocyte surface. Cellular mechanisms involved in 
the triggering of eryptosis include increase of cytosolic Ca2+ activity ([Ca2+]i), oxidative stress, 
ceramide, p38 kinase and  casein kinase 1α. The present study explored, whether Sclareol induces 
eryptosis and, if so, shed light on the mechanisms involved. Methods: Phosphatidylserine 
abundance at the erythrocyte surface was estimated from annexin-V-binding, cell volume 
from forward scatter, [Ca2+]i from Fluo3-fluorescence, abundance of reactive oxygen species 
(ROS) from 2’,7’-dichlorodihydrofluorescein diacetate (DCFDA)-dependent fluorescence, and 
ceramide abundance at the erythrocyte surface utilizing specific antibodies. Hemolysis was 
estimated from haemoglobin concentration in the supernatant. Results: A 48 hours exposure 
of human erythrocytes to Sclareol (≥ 50 µM) significantly increased the percentage of annexin-
V-binding cells without significantly modifying the average forward scatter, DCF-fluorescence 
or ceramide abundance. Sclareol (≥ 50 µM) further triggered hemolysis. Sclareol (100 µM) 
significantly increased Fluo3-fluorescence, but the effect of Sclareol on annexin-V-binding 
was not significantly blunted by removal of extracellular Ca2+. Instead, the effect of Sclareol on 
annexin-V-binding was significantly blunted in the presence of p38 kinase inhibitor skepinone 
(2 µM) and in the presence of casein kinase 1α inhibitor D4476 (10 µM). Conclusions: Sclareol 
triggers phospholipid scrambling of the erythrocyte cell membrane, an effect in part due to 
activation of p38 kinase and casein kinase 1α.
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IntroductionPlant-derived terpenoids [1] such as the diterpene alcohol Sclareol [2] are effective 
against cancer [1, 3-13], inflammation [1, 14, 15], and infection [16-18]. Sclareol further 
influences brain function [19-25]. The effect of Sclareol against cancer is partially due 
to stimulation of tumor cell apoptosis [3-5, 7, 12, 13, 26]. Sclareol is incorporated into 
phospholipid model membranes [27] and has been shown to suppress the formation of 
nitric oxide [15] and prostaglandin E2 [15].
In analogy to apoptosis of nucleated cells, erythrocytes may enter eryptosis, the suicidal 
erythrocyte death characterized by cell shrinkage [28] and cell membrane scrambling 
with phosphatidylserine translocation to the cell surface [29]. Cellular mechanisms 
accomplishing eryptosis include Ca2+ entry with increase of cytotosolic Ca2+ activity 
([Ca2+]i) [29], ceramide [30], caspases [29, 31, 32], as well as activation of casein kinase 1α, 
Janus-activated kinase JAK3, protein kinase C, and/or p38 kinase [29]. Eryptosis is further 
triggered by pharmacological inhibition or genetic knockout of AMP activated kinase, cGMP-
dependent protein kinase, and PAK2 kinase [29], by oxidative stress [29], energy depletion 
[29] and diverse xenobiotics [29, 33-64]. Eryptosis is enhanced in several clinical conditions, such as dehydration [65], hyperphosphatemia [66], chronic kidney disease (CKD) [67-70], 
hemolytic-uremic syndrome [71], diabetes [72], hepatic failure [73], malignancy  [29], sepsis 
[74], sickle-cell disease [29], beta-thalassemia [29], Hb-C and G6PD-deficiency [29], as well 
as Wilsons disease [75].
The present study analyzed Sclareol sensitivity of eryptosis. Human erythrocytes 
drawn from healthy volunteers were treated with Sclareol and phosphatidylserine surface 
abundance, cell volume, [Ca2+]i, reactive oxygen species (ROS), and ceramide abundance 
determined by flow cytometry. Moreover, the effect of Sclareol on cell membrane scrambling 
was quantified in the presence or absence of extracellular Ca2+, of p38 kinase inhibitor 
skepinone and of casein kinase 1α inhibitor D4476. 
Materials and Methods 
Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University 
of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The 
blood was centrifuged at 120 g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant was 
disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 
125 NaCl, 5 KCl, 1 MgSO
4
, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 
CaCl2, at 37°C for 48 hours. Where indicated, erythrocytes were exposed for 48 hours to Sclareol (Sigma Aldrich, 
Hamburg, Germany). To test for an involvement of p38 kinase or casein kinase 1α, erythrocytes were exposed 
for 48 hours to a combination of Sclareol and p38 kinase inhibitor skepinone [76] or casein kinase 1α inhibitor 
D4476 (Tocris bioscience, Bristol, UK), respectively.
Annexin-V-binding and forward scatter 
After incubation under the respective experimental condition, a 100 µl cell suspension was washed in 
Ringer solution containing 5 mM CaCl2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, 
Friesoythe, Germany) in this solution at 37°C for 20 min under protection from light. The annexin-V-
abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, 
Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding 
cells and control cells. The same threshold was used for untreated and Sclareol treated erythrocytes. 
Intracellular Ca2+
After incubation, erythrocytes were washed in Ringer solution and loaded with Fluo-3/AM (Biotium, 
Hayward, USA) in Ringer solution containing 5 µM Fluo-3/AM. The cells were incubated at 37°C for 30 
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min. Ca2+-dependent fluorescence intensity was measured with an excitation wavelength of 488 nm and an 
emission wavelength of 530 nm on a FACS Calibur.
Reactive oxygen species (ROS) 
Oxidative stress was determined utilizing 2’,7’-dichlorodihydrofluorescein diacetate (DCFDA). After 
incubation, a 100 µl suspension of erythrocytes was washed in Ringer solution and stained with DCFDA 
(Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. 
Erythrocytes were incubated at 37°C for 30 min in the dark and washed two times in Ringer solution. The 
DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence 
intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on 
a FACS Calibur (BD).
Ceramide abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. To this end, cells were 
stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) 
in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice 
with PBS-BSA. The cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) 
conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 
in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples 
were analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm. As a control, secondary antibody alone was used.
Hemolysis
For the determination of hemolysis, erythrocyte suspensions were centrifuged 10 min at 2000 rpm 
RT and the supernatants harvested. As a measure of hemolysis, the hemoglobin (Hb) concentration of the 
supernatants was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes 
lysed in distilled water was defined as 100% hemolysis. 
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis 
was made using ANOVA with Tukey’s test as post-test and t test as appropriate. n denotes the number of 
different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments 
are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control 
and experimental conditions.
Results
The present study explored whether Sclareol stimulates eryptosis, the suicidal 
erythrocyte death characterized by cell shrinkage and by phospholipid scrambling of the 
cell membrane with phosphatidylserine translocation to the cell surface. 
Phosphatidylserine exposing erythrocytes were identified utilizing annexin-V-binding, 
as determined by flow cytometry. Prior to measurements, the erythrocytes were incubated 
for 48 hours in Ringer solution without or with Sclareol (10 - 100 µM). As illustrated in Fig. 
1, a 48 hours exposure to Sclareol increased the percentage of phosphatidylserine exposing 
erythrocytes, an effect reaching statistical significance at 100 µM Sclareol. 
Erythrocyte volume was estimated from forward scatter which was determined utilizing 
flow cytometry. Prior to measurements, the erythrocytes were again incubated for 48 hours 
in Ringer solution without or with Sclareol (10 – 100 µM). As shown in Fig. 2, Sclareol did 
not significantly modify the average erythrocyte forward scatter, but at a concentration of 
100 µM significantly decreased the percentage of large erythrocytes (>800). 
As shown in Fig. 3, Sclareol exposure was further followed by hemolysis, an effect 
reaching statistical significance at 50 µM Sclareol. 
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Fluo3-fluorescence was determined as a measure of cytosolic Ca2+ activity ([Ca2+]i). 
As illustrated in Fig. 4, a 48 hours exposure to 100 µM Sclareol significantly increased the 
Fluo3-fluorescence, an observation pointing to increase of [Ca2+]i.
Fig. 1. Effect of Sclareol on phosphatidylserine exposure. A. Original histogram of annexin-V-binding of 
erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) 
presence of 100 µM Sclareol. B. Arithmetic means ± SEM (n = 10) of erythrocyte annexin-V-binding follow-
ing incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Sclareol (10 – 100 
µM). ***(p<0.001) indicates significant difference from the absence of Sclareol (ANOVA).
Fig. 2. Effect of Sclareol on erythrocyte forward scatter. A. Original histogram of forward scatter of erythro-
cytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) presence 
of 100 µM Sclareol. B. Arithmetic means ± SEM (n = 10) of the erythrocyte forward scatter (FSC) following 
incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Sclareol (10 - 100 µM). C. 
Arithmetic means ± SEM (n = 10) of the percentage erythrocytes with forward scatter (FSC) <200 following 
incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Sclareol (10 – 100 µM). 
D. Arithmetic means ± SEM (n = 10) of the percentage erythrocytes with forward scatter (FSC) >800 follow-
ing incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Sclareol (10 – 100 
µM). *(p<0.05) indicates significant difference from the absence of Sclareol (ANOVA).
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
Cell Physiol Biochem 2016;39:554-564
DOI: 10.1159/000445647
Published online: July 11, 2016 558
Signoretto/Laufer/Lang: Sclareol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
In order to test, whether the Sclareol-induced translocation of phosphatidylserine was 
sensitive to extracellular Ca2+, erythrocytes were incubated for 48 hours in the absence 
or presence of 50 or 100 µM Sclareol in the presence or nominal absence of extracellular 
Ca2+. As shown in Fig. 5, removal of extracellular Ca2+ did not significantly blunt the effect of 
Sclareol on the percentage of annexin-V-binding erythrocytes. Moreover, even in the absence 
of extracellular Ca2+, Sclareol significantly increased the percentage of annexin-V-binding 
erythrocytes. Thus, Sclareol-induced cell membrane scrambling was not dependent on entry 
of extracellular Ca2+.
Eryptosis is further stimulated by oxidative stress. Reactive oxygen species (ROS) were 
thus quantified utilizing 2′,7′-dichlorodihydrofluorescein (DCF) diacetate. As a result, the 
DCF-fluorescence was similar following exposure to 10 µM Sclareol (15.1 ± 0.4 a.u., n = 5), 25 
µM Sclareol (13.6 ± 0.6 a.u., n = 5) 50 µM Sclareol (12.8 ± 0.4 a.u., n = 5) and 100 µM Sclareol 
(17.4 ± 2.5 a.u., n = 5) as in the absence of Sclareol (17.3 ± 2.6 a.u., n = 5). Thus, Sclareol did 
not appreciably induce oxidative stress.
A further stimulator of eryptosis is ceramide. Ceramide abundance at the erythrocyte 
surface was thus quantified utilizing specific antibodies. As a result, the ceramide abundance 
was similar following exposure to 50 µM Sclareol (10.9 ± 0.2 a.u., n = 5) and 100 µM Sclareol 
(11.4 ± 0.2 a.u., n = 5) as in the absence of Sclareol (11.2 ± 0.3 a.u., n = 5). Thus, Sclareol did 
not appreciably induce ceramide abundance.
Fig. 3. Effect of Sclareol on hemolysis. Arithmetic 
means ± SEM (n = 10) of erythrocyte annexin-V-
binding following incubation for 48 hours to Ringer 
solution without (white bar) or with (black bars) 
Sclareol (10 - 100 µM). **(p<0.01), ***(p<0.001) 
indicates significant difference from the absence of 
Sclareol (ANOVA).
Fig. 4. Effect of Sclareol on cytosolic Ca2+ activity. A. Original histogram of Fluo3-fluorescence of erythro-
cytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) pres-
ence of 100 µM Sclareol. B. Arithmetic means ± SEM (n = 10) of erythrocyte annexin-V-binding following 
incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Sclareol (10 - 100 µM). 
***(p<0.001) indicates significant difference from the absence of Sclareol (ANOVA).
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To explore, whether the effects of Sclareol involved p38 kinase activity, the influence of 
Sclareol on annexin-V-binding was tested in the absence or presence of p38 kinase inhibitor 
skepinone (2 µM). As illustrated in Fig. 6A, the effect of 100 µM Sclareol was significantly 
blunted in the presence of skepinone. However, even in the presence of skepinone, Sclareol 
significantly increased the percentage of annexin-V-binding erythrocytes. Thus, Sclareol-
induced cell membrane scrambling was apparently in part but not fully due to activation of 
p38 kinase. 
To explore, whether the effects of Sclareol required casein kinase 1α activity, the 
influence of Sclareol on annexin-V-binding was tested in the absence or presence of casein 
kinase 1α inhibitor D4476 (10 µM). As illustrated in Fig. 6B, the effect of 100 µM Sclareol 
Fig. 5. Ca2+ sensitivity of Sclareol -induced phosphatidylserine exposure. A,B. Original histogram of annexin-
V-binding of erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with 
(black line) Sclareol (100 µM) in the presence (A) and absence (B) of extracellular Ca2+. C. Arithmetic means 
± SEM (n = 10) of annexin-V-binding of erythrocytes after a 48 hours treatment with Ringer solution without 
(white bars) or with 50 µM (black bars) or 100 µM (grey bars) Sclareol in the presence (left bars, +Ca2+) and 
absence (right bars, -Ca2+) of Ca2+. ***(p<0.001) indicates significant difference from the absence of Sclareol 
(ANOVA).
Fig. 6. Effect of p38 kinase inhibitor skepinone and of casein kinase 1α inhibitor D4476 on Sclareol -induced 
phosphatidylserine exposure. A. Arithmetic means ± SEM (n = 10) of annexin-V-binding of erythrocytes 
after a 48 hours treatment with Ringer solution without (white bars) or with 50 µM (black bars) or 100 µM 
(grey bars) Sclareol in the absence (left bars, DMSO) and presence (right bars, skepinone) of p38 kinase 
inhibitor skepinone (2 µM). B. Arithmetic means ± SEM (n = 15) of annexin-V-binding of erythrocytes after 
a 48 hours treatment with Ringer solution without (white bars) or with 50 µM (black bars) or 100 µM (grey 
bars) Sclareol in the absence (left bars, DMSO) and presence (right bars, D4476) of  casein kinase 1α inhibi-
tor D4476 (10 µM). *(p<0.05), ***(p<0.001) indicates significant difference from the absence of Sclareol, 
###(p<0.001) indicates significant difference from the absence of kinase inhibitors (ANOVA).
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was significantly blunted in the presence of D4476. However, even in the presence of D4476, 
Sclareol significantly increased the percentage of annexin-V-binding erythrocytes. Thus, 
Sclareol-induced cell membrane scrambling was again in part but not fully due to activation 
of casein kinase 1α. 
Discussion
The present observations uncover a novel stimulator of erythrocyte cell membrane 
scrambling, i.e. the diterpene alcohol Sclareol. Treatment of erythrocytes from healthy 
individuals with Sclareol results in cell membrane scrambling with phosphatidylserine 
translocation to the erythrocyte surface. 
The effect of 100 µM Sclareol on cell membrane scrambling was paralleled by an increase 
of Fluo3-fluorescence, an observation pointing to increase of cytosolic Ca2+ activity ([Ca2+]i). 
However, the effect on cell membrane scrambling was not significantly modified by removal of 
Ca2+ from extracellular space, indicating that the effect did not require entry of extracellular Ca2+. 
Moreover, the effect of Sclareol on cell membrane scrambling was not paralleled by oxidative 
stress and not by increased ceramide abundance at the erythrocyte surface. Instead, the effect of 
Sclareol on cell membrane scrambling was significantly blunted by pharmacological inhibition 
of p38 kinase and of casein kinase 1α, both kinases known to be involved in the machinery 
stimulating eryptosis [29]. However, even in the presence of the respective kinase inhibitors, 
Sclareol significantly increased the percentage of annexin-V-binding erythrocytes, indicating 
that the stimulation of eryptosis by Sclareol may involve further cellular mechanisms. Those 
mechanisms could include activation of further kinases, such as protein  kinase c or Janus-
activated kinase JAK3, as well as inhibition of kinases, such as AMPK, cGMP-dependent 
protein kinase, and PAK2 kinase [29].
Despite a significant increase of [Ca2+]i following Sclareol treatment, Sclareol had no 
significant effect on the average forward scatter. An increase of [Ca2+]i were expected to activate 
Ca2+ sensitive K+ channels leading to K+ exit, cell membrane hyperpolarization, Cl- exit and thus 
cellular loss of KCl with water [28]. Possibly, the effect of K+ channel activation on cell volume 
was abrogated by impairment of Na+/K+ ATPase with respective dissipation of chemical K+, Na+ 
and Cl- grandients.
Besides its effect on cell membrane scrambling, Sclareol triggered hemolysis with release 
of hemoglobin, which may in vivo pass the renal glomerular filter, precipitate in the acidic 
lumen of renal tubules, occlude nephrons and thus cause renal failure [77]. To the extent that 
eryptosis precedes hemolysis, those consequences are prevented due to timely removal of 
the affected erythrocytes from circulating blood. 
The loss of phosphatidylserine exposing erythrocytes may, however, lead to anemia 
as long as it is not compensated by stimulation of erythropoiesis with matching formation 
of new erythrocytes [29]. Phosphatidylserine exposing erythrocytes further bind to 
the vascular wall [78], trigger blood clotting and thus predispose to thrombosis [79-81]. 
Excessive eryptosis could thus impair microcirculation [30, 79, 82-85]. 
ConclusionIn conclusion, Sclareol triggers cell membrane scrambling, an effect partially dependent 
on activities of p38 kinase and casein kinase 1α.  
Acknowledgements
The authors acknowledge the meticulous preparation of the manuscript by Tanja Loch. 
The study was supported by the Deutsche Forschungsgemeinschaft.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
Cell Physiol Biochem 2016;39:554-564
DOI: 10.1159/000445647
Published online: July 11, 2016 561
Signoretto/Laufer/Lang: Sclareol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Disclosure Statement
The authors of this manuscript state that they have no conflicts of interest to declare.
References
1 Sultana N, Saify ZS: Enzymatic biotransformation of terpenes as bioactive agents. J Enz Inhibit Medi Chem 
2013;28:1113-1128.
2 Zerbe P, Bohlmann J: Enzymes for Synthetic Biology of Ambroxide-Related Diterpenoid Fragrance 
Compounds. Adv Biochem Eng Biotechnol 2015;148:427-447.
3 Dimas K, Hatziantoniou S, Tseleni S, Khan H, Georgopoulos A, Alevizopoulos K, Wyche JH, Pantazis P, 
Demetzos C: Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of 
HCT116 tumor growth in immunodeficient mice. Apoptosis 2007;12:685-694.
4 Dimas K, Kokkinopoulos D, Demetzos C, Vaos B, Marselos M, Malamas M, Tzavaras T: The effect of sclareol 
on growth and cell cycle progression of human leukemic cell lines. Leukemia Res 1999;23:217-234.
5 Dimas K, Papadaki A, Tsimplouli C, Hatziantoniou S, Alevizopoulos K, Pantazis P, Demetzos C: Labd-14-ene-
8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the 
activity of anticancer drugs. Biomed Pharmacother 2006;60:127-133.
6 Hatziantoniou S, Dimas K, Georgopoulos A, Sotiriadou N, Demetzos C: Cytotoxic and antitumor activity of 
liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol 
Res 2006;53:80-87.
7 Mahaira LG, Tsimplouli C, Sakellaridis N, Alevizopoulos K, Demetzos C, Han ZY, Pantazis P, Dimas K: 
The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines 
and suppression of tumor growth in vivo via a p53-independent mechanism of action. Eur J Pharmacol 
2011;666:173-182.
8 Noori S, Hassan ZM, Mohammadi M, Habibi Z, Sohrabi N, Bayanolhagh S: Sclareol modulates the Treg intra-
tumoral infiltrated cell and inhibits tumor growth in vivo. Cell Immunol 2010;263:148-153.
9 Noori S, Hassan ZM, Salehian O: Sclareol Reduces CD4+CD25+FoxP3+T-reg Cells in a Breast Cancer Model 
in Vivo. Iran J Immunol 2013;10:10-21.
10 Paradissis A, Hatziantoniou S, Georgopoulos A, Psarra AMG, Dimas K, Demetzos C: Liposomes modify 
the subcellular distribution of sclareol uptake by HCT-116 cancer cell lines. Biomed Pharmacother 
2007;61:120-124.
11 Sashidhara KV, Rosaiah JN, Kumar A, Bid HK, Konwar R, Chattopadhyay N: Cell growth inhibitory action 
of an unusual labdane diterpene, 13-epi-Sclareol in breast and uterine cancers in vitro. Phytother Res 
2007;21:1105-1108.
12 Shakeel-u-Rehman, Rah B, Lone SH, Rasool RU, Farooq S, Nayak D, Chikan NA, Chakraborty S, Behl A, 
Mondhe DM, Goswami A, Bhat KA: Design and Synthesis of Antitumor Heck-Coupled Sclareol Analogues: 
Modulation of BH3 Family Members by SS-12 in Autophagy and Apoptotic Cell Death. J Med Chem 
2015;58:3432-3444.
13 Wang L, He HS, Yu HL, Zeng Y, Han H, He N, Liu ZG, Wang ZY, Xu SJ, Xiong M: Sclareol, a plant diterpene, 
exhibits potent antiproliferative effects via the induction of apoptosis and mitochondrial membrane 
potential loss in osteosarcoma cancer cells. Mol Med Reports 2015;11:4273-4278.
14 Huang GJ, Pan CH, Wu CH: Sclareol Exhibits Anti-inflammatory Activity in Both Lipopolysaccharide-
Stimulated Macrophages and the lambda-Carrageenan-Induced Paw Edema Model. J Nat Prod 2012;75:54-
59.
15 Zhong Y, Huang Y, Santoso MB, Wu LD: Sclareol exerts anti-osteoarthritic activities in interleukin-1 
beta-induced rabbit chondrocytes and a rabbit osteoarthritis model. International J Clin Exp Pathol 
2015;8:2365-2374.
16 Choudhary ML, Siddiqui ZA, Hussain S, Atta-ur-Rahman: Structure elucidation and antibacterial activity of 
new fungal metabolites of sclareol. Chem Biodivers 2006;3:54-61.
17 Ma MF, Feng JL, Li RX, Chen SW, Xu H: Synthesis and antifungal activity of ethers, alcohols, and iodohydrin 
derivatives of sclareol against phytopathogenic fungi in vitro. Bioorg Med Chem Lett 2015;25:2773-2777.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
Cell Physiol Biochem 2016;39:554-564
DOI: 10.1159/000445647
Published online: July 11, 2016 562
Signoretto/Laufer/Lang: Sclareol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
18 Tapia L, Torres J, Mendoza L, Urzua A, Ferreira J, Pavani M, Wilkens M: Effect of 13-epi-sclareol on the 
bacterial respiratory chain. Planta Med 2004;70:1058-1063.
19 Georgieva J: Effects of the Diterpene Sclareol Glycol on Body-Temperature in Rats. Methods Find Exp Clin 
Pharmacol 1989;11:277-280.
20 Georgieva J: Effects of the Diterpene Sclareol Glycol on Convulsive Seizures. Methods Find Exp Clin 
Pharmacol 1989;11:335-340.
21 Georgieva J: Measures of Anxiety, Retention and Stress in the Rat Following Treatment with the Diterpene 
Sclareol Glycol. Methods Find Exp Clin Pharmacol 1990;12:5-10.
22 Georgieva J: The Response of Diterpene Sclareol Glycol to Acute-Hypoxia in Mice. Methods Find Exp Clin 
Pharmacol 1990;12:591-593.
23 Georgieva J, Danchev N: The Effects of the Diterpene Sclareol Glycol on Seizures Do Not Depend on Central 
Benzodiazepine Receptors. Methods Find Exp Clin Pharmacol 1990;12:679-683.
24 Georgieva JV: Diterpene Sclareol Glycol Inhibits Clonidine-Induced Aggressive Responses in Mice. 
Pharmacol Biochem Behav 1989;34:503-505.
25 Georgieva JV: Influences of Diterpene Sclareol Glycol on Some Dopamine Related Behavior. Gen Pharmacol 
1991;22:331-335.
26 Patel NR, Hatziantoniou S, Georgopoulos A, Demetzos C, Torchilin VP, Weissig V, D'Souza GGM: 
Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol. J Liposome Res 
2010;20:244-249.
27 Kyrikou I, Georgopoulos A, Hatziantoniou S, Mavromoustakos T, Demetzos C: A comparative study of the 
effects of cholesterol and sclareol, a bioactive labdane type diterpene, on phospholipid bilayers. Chem Phys 
Lipids 2005;133:125-134.
28 Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human 
erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
29 Lang E, Lang F: Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte 
death. Semin Cell Dev Biol 2015;39:35-42.
30 Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O, Gawaz M, Gulbins E, Lang F: Sphingomyelinase-
induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-
999.
31 Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP, Kong SK: In vitro effect of CTAB- and PEG-coated gold 
nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-
856.
32 Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, Ciccoli L: Erythrocyte caspase-3 
activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 
2013;50:489-495.
33 Alzoubi K, Calabròa S, Bissinger R, Abed M, Faggio C, Lang F: Stimulation of Suicidal Erythrocyte Death by 
Artesunate. Cell Physiol Biochem 2014;34:2232-2244.
34 Alzoubi K, Egler J, Abed M, Lang F: Enhanced Eryptosis Following Auranofin Exposure. Cell Physiol 
Biochem 2015;37:1018-1028.
35 Arnold M, Bissinger R, Lang F: Mitoxantrone-induced suicidal erythrocyte death. Cell Physiol Biochem 
2014;34:1756-1767.
36 Arnold M, Lang E, Modicano P, Bissinger R, Faggio C, Abed M, Lang F: Effect of nitazoxanide on 
erythrocytes. Basic Clin Pharmacol Toxicol 2014;114:421-426.
37 Bissinger R, Barking S, Alzoubi K, Liu G, Liu G, Lang F: Stimulation of Suicidal Erythrocyte Death by the 
Antimalarial Drug Mefloquine. Cell Physiol Biochem 2015;36:1395-1405.
38 Bissinger R, Bouguerra G, Stockinger K, Abbes S, Lang F: Triggering of Suicidal Erythrocyte Death by 
Topotecan. Cell Physiol Biochem 2015;37:1607-1618.
39 Bissinger R, Fischer S, Jilani K, Lang F: Stimulation of Erythrocyte Death by Phloretin. Cell Physiol Biochem 
2014;34:2256-2265.
40 Bissinger R, Lupescu A, Zelenak C, Jilani K, Lang F: Stimulation of eryptosis by cryptotanshinone. Cell 
Physiol Biochem 2014;34:432-442.
41 Bouguerra G, Aljanadi O, Bissinger R, Abbes S, Lang F: Embelin-Induced Phosphatidylserine Translocation 
in the Erythrocyte Cell Membrane. Cell Physiol Biochem 2015;37:1629-1640.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
Cell Physiol Biochem 2016;39:554-564
DOI: 10.1159/000445647
Published online: July 11, 2016 563
Signoretto/Laufer/Lang: Sclareol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
42 Bouguerra G, Bissinger R, Abbes S, Lang F: Stimulation of Eryptosis by Narasin. Cell Physiol Biochem 
2015;37:1807-1816.
43 Bouguerra G, Bissinger R, Abbes S, Lang F: Zopolrestat Induced Suicidal Death of Human Erythrocytes. Cell 
Physiol Biochem 2015;37:1537-1546.
44 Briglia M, Fazio A, Faggio C, Laufer S, Alzoubi K, Lang F: Triggering of Suicidal Erythrocyte Death by 
Ruxolitinib. Cell Physiol Biochem 2015;37:768-778.
45 Briglia M, Fazio A, Signoretto E, Faggio C, Lang F: Edelfosine Induced Suicidal Death of Human 
Erythrocytes. Cell Physiol Biochem 2015;37:2221-2230.
46 Calabro S, Alzoubi K, Faggio C, Laufer S, Lang F: Triggering of Suicidal Erythrocyte Death Following 
Boswellic Acid Exposure. Cell Physiol Biochem 2015;37:131-142.
47 Egler J, Lang F: Licochalcone A Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 
2015;37:2060-2070.
48 Faggio C, Alzoubi K, Calabro S, Lang F: Stimulation of suicidal erythrocyte death by PRIMA-1. Cell Physiol 
Biochem 2015;35:529-540.
49 Fazio A, Briglia M, Faggio C, Alzoubi K, Lang F: Stimulation of Suicidal Erythrocyte Death by Garcinol. Cell 
Physiol Biochem 2015;37:805-815.
50 Jacobi J, Lang E, Bissinger R, Frauenfeld L, Modicano P, Faggio C, Abed M, Lang F: Stimulation of erythrocyte 
cell membrane scrambling by mitotane. Cell Physiol Biochem 2014;33:1516-1526.
51 Lang E, Jilani K, Bissinger R, Rexhepaj R, Zelenak C, Lupescu A, Lang F, Qadri SM: Vitamin D-Rich Diet in 
Mice Modulates Erythrocyte Survival. Kidney Blood Press Res 2015;40:403-412.
52 Lang E, Zelenak C, Eberhard M, Bissinger R, Rotte A, Ghashghaeinia M, Lupescu A, Lang F, Qadri SM: Impact 
of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis. Cell Physiol Biochem 2015;37:1178-1186.
53 Lupescu A, Bissinger R, Goebel T, Salker MS, Alzoubi K, Liu G, Chirigiu L, Mack AF, Qadri SM, Lang 
F: Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem 
2015;36:773-783.
54 Lupescu A, Bissinger R, Herrmann T, Oswald G, Jilani K, Lang F: Induction of suicidal erythrocyte death by 
novobiocin. Cell Physiol Biochem 2014;33:670-680.
55 Lupescu A, Bissinger R, Warsi J, Jilani K, Lang F: Stimulation of erythrocyte cell membrane scrambling by 
gedunin. Cell Physiol Biochem 2014;33:1838-1848.
56 Malik A, Bissinger R, Calabro S, Faggio C, Jilani K, Lang F: Aristolochic Acid Induced Suicidal Erythrocyte 
Death. Kidney Blood Press Res 2014;39:408-419.
57 Officioso A, Alzoubi K, Manna C, Lang F: Clofazimine Induced Suicidal Death of Human Erythrocytes. Cell 
Physiol Biochem 2015;37:331-341.
58 Oswald G, Alzoubi K, Abed M, Lang F: Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin 
Pharmacol Toxicol 2014;114:311-317.
59 Peter T, Bissinger R, Enkel S, Alzoubi K, Oswald G, Lang F: Programmed erythrocyte death following in vitro 
Treosulfan treatment. Cell Physiol Biochem 2015;35:1372-1380.
60 Stockinger K, Bissinger R, Bouguerra G, Abbes S, Lang F: Enhanced Eryptosis Following Exposure to 
Carnosic Acid. Cell Physiol Biochem 2015;37:1779-1791.
61 Tesoriere L, Attanzio A, Allegra M, Cilla A, Gentile C, Livrea MA: Oxysterol mixture in hypercholesterolemia-
relevant proportion causes oxidative stress-dependent eryptosis. Cell Physiol Biochem 2014;34:1075-
1089.
62 Waibel S, Bissinger R, Bouguerra G, Abbes S, Lang F: Saquinavir Induced Suicidal Death of Human 
Erythrocytes. Cell Physiol Biochem 2015;37:1973-1982.
63 Zierle J, Bissinger R, Egler J, Lang F: Lapatinib Induced Suicidal Death of Human Erythrocytes. Cell Physiol 
Biochem 2015;37:2275-2287.
64 Pagano M, Faggio C: The use of erythrocyte fragility to assess xenobiotic cytotoxicity. Cell Biochem Funct 
2015;33:351-355.
65 Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C, Towhid ST, Lang F: Sensitization 
of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 
2013;37:567-578.
66 Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F: Stimulation of suicidal erythrocyte death by 
increased extracellular phosphate concentrations. Kidney Blood Press Res 2013;38:42-51.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
Cell Physiol Biochem 2016;39:554-564
DOI: 10.1159/000445647
Published online: July 11, 2016 564
Signoretto/Laufer/Lang: Sclareol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
67 Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Foller M, Lang F: Suicidal erythrocyte death in end-
stage renal disease. J Mol Med (Berl) 2014;92:871-879.
68 Ahmed MS, Langer H, Abed M, Voelkl J, Lang F: The uremic toxin acrolein promotes suicidal erythrocyte 
death. Kidney Blood Press Res 2013;37:158-167.
69 Polak-Jonkisz D, Purzyc L: Ca(2+) influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 
2012;34:209-210; author reply 210.
70 Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, 
Carrera-Gracia MA, Quintanar-Escorza MA: Eryptosis and oxidative damage in type 2 diabetic mellitus 
patients with chronic kidney disease. Mol Cell Biochem 2011;357:171-179.
71 Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, 
Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in 
recurrent hemolytic uremic syndrome. J Mol Med (Berl) 2006;84:378-388.
72 Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, Jr., Thornalley PJ, Schleicher 
E, Wieder T, Lang F: Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 
2006;18:223-232.
73 Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, Orth HM, Klindt C, Schuier M, Keitel V, Reich 
M, Liu G, Schmidt S, Xu HC, Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E, Lang F, Haussinger 
D, Lang KS, Foller M, Lang PA: Conjugated bilirubin triggers anemia by inducing erythrocyte death. 
Hepatology 2015;61:275-284.
74 Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher 
U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med 
(Berl) 2007;85:273-281.
75 Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, 
Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, 
Lang F: Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat 
Med 2007;13:164-170.
76 Koeberle SC, Romir J, Fischer S, Koeberle A, Schattel V, Albrecht W, Grutter C, Werz O, Rauh D, Stehle T, 
Laufer SA: Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. Nature Chemical 
Biology 2012;8:141-143.
77 Harrison HE, Bunting H, Ordway NK, Albrink WS: The Pathogenesis of the Renal Injury Produced in the Dog 
by Hemoglobin or Methemoglobin. J Exp Med 1947;86:339-356.
78 Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M, Gawaz M, Lang F: Dynamic adhesion 
of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 
2012;302:C644-C651.
79 Andrews DA, Low PS: Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
80 Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces 
thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in 
human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-421.
81 Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol 
Life Sci 2005;62:971-988.
82 Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to 
vascular endothelium. Br J Haematol 1999;107:300-302.
83 Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS: Altered erythrocyte endothelial 
adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-
4627.
84 Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, 
Bonomini M: Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured 
endothelial cells. J Cell Physiol 2007;213:699-709.
85 Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-
cytometric measurement and clinical associations. Blood 1996;88:1873-1880.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
19
3.
14
9 
- 1
/1
6/
20
17
 1
0:
57
:5
2 
AM
